CaNCURE is a partnership between Northeastern University and
Dana-Farber / Harvard Cancer Center funded by the National Cancer Institute.
Cell and Molecular Biology, '21
Use of CT Texture Analysis for Characterization and Prognostication of Incidental Adnexal Lesions
Health Science, '19
Development of Smart INCeRT Brachytherapy Spacers via PLGA and Docetaxel for Combined Chemo-Radiation Therapies in Prostate Cancer
Health Sciences, '19
Investigating the use of Feraheme to monitor the immune response by PET in general inflammation and specific immune cell populations
Health Sciences, '19
Investigation of a miRNA associated with cancer metastasis. Proj 2-Development of a novel nanoparticle for MPI analysis of thromboses
Health Sciences, '19
Characterization of Targeted PARP-inhibitor Nanoformulations In Vitro and In Vivo
Biochemistry, '20
Discovering the Genetic Mechanism of Enhanced Metastatic Colonization in SMAD4 Mutant Tumors
Health Science, '19
PDT and PIT with Chemotherapy for Treatment of 3D Ovarian Cancer Nodules Under Flow and Static Conditions
Health Science, '19
Evaluation of deep learning approaches in an integrated PET/MRI scanner to generate pelvis attenuation maps and characterize prostate cancer
Health Sciences, '16
MCT1 Transporter Inhibition of IMR90 Cells Expressing Inducible Merkel Cell Carcinoma Small T Antigen
Health Sciences, '18
Protein-encapsulated nanoparticles for oral delivery of anti-mitotic agents in prostate cancer
Bioengineering, '19
Development of a Point of Care Assay for Detecting High Risk HPV in Resource Limited Settings
Biology, '18
Radiotherapeutic synergism of thermogelling cisplatin-loaded polymers for cervical cancer treatment
Health Science, '17
Combined delivery of targeted liposomal chemotherapeutics and photodynamic therapy to treat pancreatic cancer
Health Science, '18
Delivery of Titanium Dioxide Nanoparticles via Biodegradable PLGA Dissolving Microneedles for Sustainable Release
Health Sciences, '16
Pharmacokinetic analysis of changes in temozolomide distribution after antiangiogenic treatment of glioblastoma
Biology, '16
Software with built-in neuroanatomy atlas provides insight into cancer treatment
Biology/English, '17
Tracking pancreatic adenocarcinoma response to treatment using targeted, multi-modal nanoparticles
Cell and Molecular Bio, '18
Development of a novel nanogel for non-invasive transdermal delivery of cancer vaccines using hyaluronic acid
Biochemistry, '16
Capture of circulating tumor DNA through the use of biotinylated poly-lysine affixed to gold nanoparticles
Biology, '19
Analysis of DREAM and E2F1 Competition for Cell Cycle Promoters during G1.
Biology, '16
Erythropoietin improves antitumor immune response through reversal of the hypoxic tumor microenvironment
Health Sciences, '17
Optimizing murine cells for in vitro modeling of high-grade serous ovarian cancer
Health Sciences, '17
Uptake and localization of nanoparticles in prostate and lung cancer cells as a function of time and nanoparticle type
Behavioral Neurosci., '16
Co-delivery of antibiotics and topoisomerase inhibitors to overcome chemoresistance
Behavioral Neurosci, '17
Localized chemo- and chemo-radiation for the treatment of prostate cancer
Biomedicial Physics, '17
Implementation of novel MR-based attenuation correction in PET/MR pelvic scans
Biology, '19
Assessment of neoadjuvant therapy-induced atherosclerotic changes using ferumoxytol-enhanced MR imaging
Mechanical Engineering, '20
Assessment of Atherosclerotic Changes using Ferumoxytol as MRI Contrast Agent
Health Sciences, '16
Nano-plasmonic exosome (nPLEX) assays for exosome analysis and antibody validation
Physics, '17
Longitudinal assessment of tumor heterogeneity during immunotherapy for metastatic melanoma
Biochemistry, '18
Identification of novel therapeutic targets of the Notch1 signaling pathway
Health Sciences, '16
T1-weighted imaging of primary pancreatic adenocarcinoma using magnetic ferumoxytol nanoparticles
Biology/Math, '17
Biological mechanisms of gold nanoparticle-enhanced radiation therapy of prostate cancer
Health Science, '18
The Assessment and Comparison of Ferumoxtran as Contrast Imaging Agent in Patients with Pancreatic Cancers.
Biochemistry, '18
Injectable thermogelling cisplatin-loaded hydrogels for combined chemo-radiation therapy in cervical cancer
Behavioral Neurosci., '16
Clinical immunotherapy application in metastatic glioblastoma
Chemical Engineering, '18
Nanoencapsulation of tyrosine kinase inhibitors and their effects on pathway inhibition
Behavioral Neurosci, '19
Assessing the reproducibility of MRI-based brain tumor measurements between both observers and MRI vendors
Health Science, '18
miRNA analysis in mouse model of metastatic breast cancer. (Proj 2) The inhibition of PD-L1 on a Pan02 cell line w/ siRNA-nanodrug & gemcitabine treatment
Health Sciences, '16
Identifying genomic and compound dependencies in undifferentiated sarcomas
Biochemistry, '19
Development of PSMA-targeting nanoparticles for positron emitting tomography imaging in prostate cancer using animal models
Health Science, '18
Co-delivery of protective substrate and chemotherapy drugs via lipid Bilayer Mesoporous Silica Nanoparticles
Behavioral Neurosci, '17
Radiation enhancement in cancer cells using gold and gadolinium nanoparticles
Health Science, '18
Online monitoring and image-guided treatment of chemoresistant micrometastases
Health Sciences, '16
Mechanistic and modeling studies of lipid nanoemulsions impact on oral lapatinib absorption
Chemical Engineering, '19
In vivo imaging of targeted drug delivery to HER2 positive cancer cells
Health Sciences, '17
Investigating the use of iron chelator deferoxamine (DFO)-bearing PEG-like nanoprobes as a multifunctional agent for cancer therapy and PET imaging
Health Sciences, '16
Targeting CXCR4/SDF-1a using phytochemicals to inhibit progression and metastasis of pancreatic cancer
Chemical Engineering, '16
Optimization of macrophage-targeted nanoparticles for positron emission tomography imaging in cancer
Biochemistry, '16
Quantification of SPION accumulation in tumors using positive-contrast MRI
Chemical Engineering, '17
Surface-targeting, ligand-switching nanoparticles for mitochondrial drug delivery in prostate cancer
Health Science, '18
Use of a Triblock Copolymer Hydrogel for Controlled Release of Cisplatin and BMN-673
Health Sciences, '16
Iron-chelating PEG-like nanoprobes as therapeutic and 89Zr/PET imaging agents
“CaNCURE presented me with so many opportunities to explore the world of medicine, both inside and outside of the lab. I am eternally grateful for the connections I have made through CaNCURE at DFCI. In fact, I consulted both my day-today mentor and my PI when deciding between offers for my second co-op cycle.”